Showing results (1391-1400 of 2,389) with videos related to
Sort By:
Pageof 239
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Roles of Ileal ASBT and OSTα-OSTβ in Regulating Bile Acid SignalingPaul A DawsonDigestive Diseases (Basel, Switzerland)|March 2, 2017
Intestinal Farnesoid X Receptor Signaling Modulates Metabolic DiseaseFrank J Gonzalez, Changtao Jiang, Cen Xie, et al.Digestive Diseases (Basel, Switzerland)|March 2, 2017
Mechanisms of Tauroursodeoxycholate-Mediated HepatoprotectionDieter Häussinger, Claus KordesDigestive Diseases (Basel, Switzerland)|March 2, 2017
Farnesoid X Receptor an Emerging Target to Combat ObesityC Daniel De Magalhaes Filho, Michael Downes, Ronald M EvansDigestive Diseases (Basel, Switzerland)|March 2, 2017
Bile Acid Uptake Transporters as Targets for TherapyDavor Slijepcevic, Stan F J van de GraafDigestive Diseases (Basel, Switzerland)|March 8, 2017
Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol GallstoneHyo Jung Kim, Jae Seon Kim, Seikwan Oh, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2016
Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2Kayo Sugimoto, Soo Ki Kim, Soo Ryang Kim, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2016
Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2Naoshi Nishida, Masashi Kono, Tomohiro Minami, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2016
Comparison of Two-Dimensional Shear Wave Elastography and Real-Time Tissue Elastography for Assessing Liver Fibrosis in Chronic Hepatitis BTao Wu, Ping Wang, Ting Zhang, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2016
Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver CirrhosisHirokazu Chishina, Satoru Hagiwara, Naoshi Nishida, et al.Pageof 239